PBT swung to a $19.5m loss despite underlying EBITDA up 2.7%

What changed

Revenue was effectively flat at NZD 132.6m (+0.8%) and underlying EBITDA rose modestly to NZD 38.6m (+2.7%). Below that line the result inverted: PBT went from a NZD 32.4m profit to a NZD 19.5m loss (-160.3%), and NPAT from NZD 35.2m to a NZD 17.1m loss (-148.5%). The PBT-to-NPAT gap is small, so the collapse is not a tax artefact — it sits in items between underlying EBITDA and statutory PBT (fair-value movements, depreciation and finance costs are the usual drivers in this sector but are not itemised in the extract).

Operating cash inflow jumped to NZD 70.4m from NZD 48.0m (+46.6%), driven largely by a NZD 100.8m reduction in trade receivables (to NZD 20.7m from NZD 121.5m). Gross borrowings rose to NZD 639.0m (+NZD 17.6m) and cash to NZD 13.0m; management cites gearing of 37.5% versus 38.3% at FY24. Segment mix shows Care Operations swinging to a NZD 17.6m segment loss from a NZD 2.1m profit, while Village Operations remained the profit engine but at materially lower absolute EBITDA (NZD 34.0m vs NZD 56.4m). No interim dividend was declared.

What matters

• Care Operations has turned loss-making. On roughly 75.8% of group revenue, Care flipped from a small positive segment result to a NZD 17.6m loss. That is the single biggest read-through for operating earnings quality — the "underlying EBITDA +2.7%" headline relies heavily on Village and masks deterioration in the largest revenue pool.
• The statutory loss is structural, not tax-driven. The effective tax rate moved only modestly (from -8.6% to -12.5%) and PBT fell by NZD 51.9m. PBT is the cleaner operating read here, and it says the result is materially worse than the non-GAAP EBITDA line suggests. The extracted materials do not provide a full bridge from underlying EBITDA to statutory PBT.
• Leverage is flat, not falling meaningfully. Net debt sits at NZD 625.9m and net debt/underlying EBITDA is essentially unchanged at ~16.2x on a trailing-HY basis. Management's reported gearing drop (37.5% vs 38.3%) reflects higher asset and equity values (total equity up to NZD 1b) rather than debt reduction — gross borrowings actually rose NZD 17.6m.

Expectations

No explicit FY25 quantitative guidance was disclosed in the extracted materials. The FY24 shape shows a second-half-weighted base (HY24 was 49.6% of FY24 revenue and only 45.6% of FY24 EBITDA), so a stronger 2H is the historical norm. HY25 annualises to NZD 265.2m of revenue, almost identical to FY24's NZD 265.5m — there is no evidence in this release of a step-change in the revenue run-rate. Management commentary points to sales capability, portfolio rebalancing and lifting Care profitability, but does not quantify those. The release supports a directional case for 2H seasonal improvement; it does not support any specific earnings trajectory.

Quality of result

The cash result is flattered by working capital. OCF/EBITDA of 182% versus 127.5% last year is driven by the NZD 100.8m receivables run-down — receivable days fell from ~168 to ~28. That is a one-off collection effect, not recurring cash generation, and should not be annualised. Pre-lease free cash flow of NZD 41.2m is therefore not a clean proxy for sustainable FCF. Capex at ~22% of revenue remains high.

On the P&L, the underlying EBITDA uplift is narrow: revenue growth was <1% and the improvement came despite Care turning loss-making at the segment level, implying Village and fair-value / non-operating line items carried the headline. With no disclosed non-recurring items and no full non-GAAP reconciliation in the extract, the gap between "underlying EBITDA +2.7%" and "PBT -NZD 19.5m" is the quality issue.

Unresolved

• What drove the NZD 51.9m PBT swing between underlying EBITDA and statutory PBT — fair-value movements on investment property, higher depreciation, higher finance costs, or something else?
• Why did Care Operations swing to a NZD 17.6m segment loss on essentially flat revenue, and is the cost base change structural?
• Is the Village segment's lower absolute profit (NZD 34.0m vs NZD 56.4m) a timing effect in resales/new sales, or a shift in underlying economics?
• What drove the NZD 100.8m receivables collection, and what is the normalised receivables level going forward?
• With gross debt rising and no dividend declared, what is the stated capital allocation priority into 2H?

This briefing cannot assess Oceania's valuation, liquidity headroom against specific covenant thresholds, or the durability of 2H earnings, because NTA per share, covenant detail, forward-work metrics and quantitative guidance were not in the extracted materials.

Key metrics

Segment breakdown

Analytical metrics

---

This analysis was generated using Annolyse, an AI-powered tool that analyses NZX company announcements. The analysis is based on available company filings and standard Annolyse calculations. This is general information only and does not constitute financial advice. The analysis may contain errors. Always read the original company filings and consult a licensed financial adviser before making investment decisions.